H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Price:
24.5
HKD
3.81%
Market Closed
Market Cap:
145.4B
HKD
Income Statement
Earnings Waterfall
Hansoh Pharmaceutical Group Company Ltd
Hansoh Pharmaceutical Group Company Ltd
|
Revenue
|
12.3B
CNY
|
|
Cost of Revenue
|
-1.1B
CNY
|
|
Gross Profit
|
11.2B
CNY
|
|
Operating Expenses
|
-6.1B
CNY
|
|
Operating Income
|
5.1B
CNY
|
|
Other Expenses
|
-685m
CNY
|
|
Net Income
|
4.4B
CNY
|
Income Statement
Hansoh Pharmaceutical Group Company Ltd
Hansoh Pharmaceutical Group Company Ltd
Currency: CNY
Millions
TTM
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue |
8 683
N/A
|
8 063
-7%
|
8 690
+8%
|
9 112
+5%
|
9 935
+9%
|
9 968
+0%
|
9 382
-6%
|
9 459
+1%
|
10 104
+7%
|
12 098
+20%
|
12 261
+1%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(730)
|
(705)
|
(803)
|
(859)
|
(870)
|
(853)
|
(870)
|
(1 002)
|
(1 033)
|
(1 087)
|
(1 105)
|
|
| Gross Profit |
7 953
N/A
|
7 357
-7%
|
7 887
+7%
|
8 253
+5%
|
9 065
+10%
|
9 115
+1%
|
8 512
-7%
|
8 457
-1%
|
9 071
+7%
|
11 011
+21%
|
11 155
+1%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(5 155)
|
(4 667)
|
(5 103)
|
(5 399)
|
(6 105)
|
(6 312)
|
(5 947)
|
(6 077)
|
(6 425)
|
(6 797)
|
(6 099)
|
|
| Selling, General & Administrative |
(4 043)
|
(3 639)
|
(3 861)
|
(4 027)
|
(4 372)
|
(4 387)
|
(4 155)
|
(4 184)
|
(4 263)
|
(4 339)
|
(4 508)
|
|
| Research & Development |
(1 121)
|
(1 039)
|
(1 252)
|
(1 463)
|
(1 797)
|
(1 849)
|
(1 693)
|
(1 884)
|
(2 097)
|
(2 364)
|
(2 702)
|
|
| Other Operating Expenses |
8
|
12
|
11
|
90
|
64
|
(76)
|
(99)
|
(9)
|
(64)
|
(94)
|
1 111
|
|
| Operating Income |
2 798
N/A
|
2 691
-4%
|
2 784
+3%
|
2 854
+3%
|
2 960
+4%
|
2 803
-5%
|
2 566
-8%
|
2 380
-7%
|
2 647
+11%
|
4 213
+59%
|
5 057
+20%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
212
|
274
|
315
|
294
|
336
|
453
|
372
|
545
|
1 107
|
1 259
|
55
|
|
| Non-Reccuring Items |
(9)
|
(15)
|
(0)
|
4
|
4
|
6
|
11
|
15
|
13
|
(21)
|
(26)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(67)
|
0
|
|
| Pre-Tax Income |
3 001
N/A
|
2 949
-2%
|
3 098
+5%
|
3 152
+2%
|
3 300
+5%
|
3 262
-1%
|
2 948
-10%
|
2 939
0%
|
3 766
+28%
|
5 384
+43%
|
5 085
-6%
|
|
| Net Income | ||||||||||||
| Tax Provision |
(444)
|
(467)
|
(529)
|
(514)
|
(587)
|
(542)
|
(365)
|
(365)
|
(489)
|
(670)
|
(713)
|
|
| Income from Continuing Operations |
2 557
|
2 483
|
2 569
|
2 638
|
2 713
|
2 720
|
2 584
|
2 575
|
3 278
|
4 714
|
4 372
|
|
| Net Income (Common) |
2 557
N/A
|
2 483
-3%
|
2 569
+3%
|
2 638
+3%
|
2 713
+3%
|
2 720
+0%
|
2 584
-5%
|
2 575
0%
|
3 278
+27%
|
4 714
+44%
|
4 372
-7%
|
|
| EPS (Diluted) |
0.47
N/A
|
0.43
-9%
|
0.44
+2%
|
0.43
-2%
|
0.44
+2%
|
0.46
+5%
|
0.44
-4%
|
0.43
-2%
|
0.54
+26%
|
0.78
+44%
|
0.73
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
